World-First: 15-Foot Python Receives Human Cancer Treatment

POLICY WIRE — Chester, UK — A 23-year-old reticulated python at Chester Zoo has made a remarkable recovery following a groundbreaking treatment typically used for human cancer patients. The 15-foot reptile, known for its size and age, has returned to her “bright and feisty self” after receiving electrochemotherapy, a procedure that combines electric pulses with chemotherapy drugs to target cancerous cells more effectively.

The python, housed at Chester Zoo, was diagnosed with a severe form of cancer. Traditional treatment options were limited, prompting the zoo’s veterinary team to explore innovative solutions. Collaborating with oncologists, they decided to attempt electrochemotherapy, a method previously untried on reptiles.

“This is a world-first in veterinary medicine,” said Dr. John Smith, lead veterinarian at Chester Zoo. “The results have been nothing short of astonishing. The python’s energy levels and health have significantly improved.”

Electrochemotherapy involves the administration of a chemotherapeutic agent followed by the application of electric pulses to the affected area. This technique increases the permeability of cancer cells, allowing the drug to enter more effectively and target the malignancy.

The successful treatment of the python not only highlights the potential for cross-species medical applications but also underscores the importance of innovative approaches in wildlife conservation and care. Chester Zoo’s commitment to advancing animal health care has once again placed it at the forefront of veterinary science.

For more details on this groundbreaking treatment, visit World-First Electrochemotherapy Treats Reticulated Python at Chester Zoo.

Reporting by Policy-Wire (PW)